Literature DB >> 22637478

Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability.

Cristhiaan D Ochoa1, Mikhail Alexeyev, Viktoriya Pastukh, Ron Balczon, Troy Stevens.   

Abstract

Exotoxin Y (ExoY) is a type III secretion system effector found in ~ 90% of the Pseudomonas aeruginosa isolates. Although it is known that ExoY causes inter-endothelial gaps and vascular leak, the mechanisms by which this occurs are poorly understood. Using both a bacteria-delivered and a codon-optimized conditionally expressed ExoY, we report that this toxin is a dual soluble adenylyl and guanylyl cyclase that results in intracellular cAMP and cGMP accumulation. The enzymatic activity of ExoY caused phosphorylation of endothelial Tau serine 214, accumulation of insoluble Tau, inter-endothelial cell gap formation, and increased macromolecular permeability. To discern whether the cAMP or cGMP signal was responsible for Tau phosphorylation and barrier disruption, pulmonary microvascular endothelial cells were engineered for the conditional expression of either wild-type guanylyl cyclase, which synthesizes cGMP, or a mutated guanylyl cyclase, which synthesizes cAMP. Sodium nitroprusside stimulation of the cGMP-generating cyclase resulted in transient Tau serine 214 phosphorylation and gap formation, whereas stimulation of the cAMP-generating cyclase induced a robust increase in Tau serine 214 phosphorylation, gap formation, and macromolecular permeability. These results indicate that the cAMP signal is the dominant stimulus for Tau phosphorylation. Hence, ExoY is a promiscuous cyclase and edema factor that uses cAMP and, to some extent, cGMP to induce the hyperphosphorylation and insolubility of endothelial Tau. Because hyperphosphorylated and insoluble Tau are hallmarks in neurodegenerative tauopathies such as Alzheimer disease, acute Pseudomonas infections cause a pathophysiological sequela in endothelium previously recognized only in chronic neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22637478      PMCID: PMC3408204          DOI: 10.1074/jbc.M111.301440

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance.

Authors:  Kevin Lowe; Diego F Alvarez; Judy A King; Troy Stevens
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

2.  Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA.

Authors:  Martin Göttle; Stefan Dove; Frieder Kees; Jens Schlossmann; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Volkhard Kaever; Roland Seifert
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

3.  Cold exposure reveals two populations of microtubules in pulmonary endothelia.

Authors:  Cristhiaan D Ochoa; Troy Stevens; Ron Balczon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

Review 4.  Myosin light chain kinase in microvascular endothelial barrier function.

Authors:  Qiang Shen; Robert R Rigor; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-05-17       Impact factor: 10.787

5.  Caspase activation precedes and leads to tangles.

Authors:  Alix de Calignon; Leora M Fox; Rose Pitstick; George A Carlson; Brian J Bacskai; Tara L Spires-Jones; Bradley T Hyman
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

Review 6.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

Review 7.  The tau of MARK: a polarized view of the cytoskeleton.

Authors:  Dorthe Matenia; Eva-Maria Mandelkow
Journal:  Trends Biochem Sci       Date:  2009-06-24       Impact factor: 13.807

8.  Critical role for lactate dehydrogenase A in aerobic glycolysis that sustains pulmonary microvascular endothelial cell proliferation.

Authors:  Glenda Parra-Bonilla; Diego F Alvarez; Abu-Bakr Al-Mehdi; Mikhail Alexeyev; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-30       Impact factor: 5.464

9.  Protein kinase A phosphorylation of tau-serine 214 reorganizes microtubules and disrupts the endothelial cell barrier.

Authors:  Bing Zhu; Li Zhang; Judy Creighton; Mikhail Alexeyev; Samuel J Strada; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-16       Impact factor: 5.464

10.  A retro-lentiviral system for doxycycline-inducible gene expression and gene knockdown in cells with limited proliferative capacity.

Authors:  Mikhail F Alexeyev; Rafik Fayzulin; Inna N Shokolenko; Viktoriya Pastukh
Journal:  Mol Biol Rep       Date:  2009-08-05       Impact factor: 2.316

View more
  52 in total

1.  Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Authors:  David M Anderson; Jimmy B Feix; Andrew L Monroe; Francis C Peterson; Brian F Volkman; Arthur L Haas; Dara W Frank
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

2.  The novel function of JADE1S in cytokinesis of epithelial cells.

Authors:  Nirodhini S Siriwardana; Rosana D Meyer; Maria V Panchenko
Journal:  Cell Cycle       Date:  2015-07-07       Impact factor: 4.534

3.  Nosocomial Pneumonia Elicits an Endothelial Proteinopathy: Evidence for a Source of Neurotoxic Amyloids in Critically Ill Patients.

Authors:  Mike T Lin; Ron Balczon; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; K Adam Morrow; Sarah Voth; C Michael Francis; Silas Leavesley; Jessica Bell; Diego F Alvarez; Troy Stevens
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

4.  Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids.

Authors:  Ron Balczon; K Adam Morrow; Chun Zhou; Bradley Edmonds; Mikhail Alexeyev; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Silas Leavesley; Xiangming Zha; Dara W Frank; Troy Stevens
Journal:  FASEB J       Date:  2017-03-17       Impact factor: 5.191

Review 5.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

6.  Lipopolysaccharide-induced pulmonary endothelial barrier disruption and lung edema: critical role for bicarbonate stimulation of AC10.

Authors:  Jordan Nickols; Boniface Obiako; K C Ramila; Kevin Putinta; Sarah Schilling; Sarah L Sayner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-16       Impact factor: 5.464

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  α-Tocopherol Attenuates the Severity of Pseudomonas aeruginosa-induced Pneumonia.

Authors:  Brant M Wagener; Naseem Anjum; Cilina Evans; Angela Brandon; Jaideep Honavar; Judy Creighton; Maret G Traber; Robert L Stuart; Troy Stevens; Jean-Francois Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

10.  SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function.

Authors:  Havovi Chichger; Julie Braza; Huetran Duong; Elizabeth O Harrington
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.